If you wait until the January renewal meeting to look hard at your health and protection figures, you are already too late. For employers, that meeting is usually the uncomfortable moment when escalating costs become undeniable. For brokers, it is the moment you realise the chance to do anything meaningful about those costs slipped away months ago. Scrambling for data in the final quarter of the year is not a renewal strategy; it is an autopsy.
What actually works is continuous workforce health intelligence. You need an evolving, joined-up view of claims, absence trends, service engagement, utilisation, and underlying operational risk. That continuous perspective gives brokers the lead time needed to separate fleeting noise from genuine, systemic failure. The 90-day renewal window should be the execution phase of a strategy you have already proven, not the day you start digging through spreadsheets to figure out what went wrong.
January exposes decisions made earlier
January renewals collide with every competing priority in the business. Employers are staring down premium spikes, wrestling over terms, questioning whether anyone even uses their benefits, and deciding whether to switch carriers or restructure funding. Meanwhile, HR is swamped by post-Christmas absence spikes, Finance is shutting down year-end budgets, and Risk leaders are trying to gauge whether exposure is escalating out of control.
This pile-up creates a predictable failure mode: renewals end up running on stale, fragmented data. Claims reports land on desks months after the fact. Absence tracking is messy and inconsistent across divisions. Annual employee surveys sit completely detached from insurer reporting, making real trend analysis impossible. In my experience, by the time a broker finally spots an emerging health crisis, the clock has run down. There is simply no runway left to trial an intervention, let alone prove to an underwriter that it worked.
The financial fallout is direct and painful. Employers shell out substantial premiums for benefit suites that fail to touch their core health risks, while insurers price blind, penalising the client for an incomplete picture of population health. The broker gets forced into a corner, reduced to haggling over margins and defending an outdated programme instead of actively shaping next year's risk profile.
Workforce health simply does not stay still for twelve months. Figures from the Health and Safety Executive show that 1.7 million workers across Great Britain suffered from work-related ill health in 2023/24, with stress, depression, or anxiety driving 776,000 of those cases. The same HSE reporting registered 33.7 million working days lost to work-related illness and non-fatal workplace injuries over the period. These are not static metrics for an annual report. They are active, shifting liabilities eroding productivity, spiking benefit claims, and testing the credibility of your risk management.
The renewal window is too short for discovery
You cannot improve an employer's risk profile if you only start investigating it when the renewal submission is due. A 90-day window gives you enough room to negotiate rates, prioritise options, and execute contracts, but it is nowhere near long enough to determine root causes.
Take a sudden spike in musculoskeletal claims. The default, knee-jerk reaction is to widen physiotherapy provisions or roll out generic ergonomic assessments. Without continuous data, however, you have no idea what you are solving for. Is the surge isolated to a single distribution centre, concentrated within a specific operational role, linked to long-term sickness records, or merely the result of earlier reporting and better employee awareness? Each scenario demands a completely different remedy.
The exact same challenge applies to mental health. A surge in therapy uptake could signal acute psychological distress, but it could equally point to better access pathways, lower stigma, or relaxed eligibility criteria. A single annual snapshot cannot tell those stories apart. Continuous monitoring allows you to cross-reference benefit utilisation with absence figures, operational restructuring, line-manager referrals, and workforce sentiment.
This demands an evolution in how brokers operate. Simply brokering terms and placing policies is a commoditised exercise. The genuine commercial value sits in taking disjointed health data points and turning them into an operational risk narrative robust enough to shape business behaviour, programme architecture, and underwriting appetite.
The broader environment leaves no margin for error. The Office for National Statistics reported that 2.8 million people were economically inactive due to long-term sickness in the quarter to June 2024, up by more than 400,000 compared to early 2020. While that is a macroeconomic figure rather than an individual claims record, it demonstrates why health cannot be treated as an annual insurance review. Every employer is competing in a labour market constrained by chronic, health-driven absence.
Continuous data changes the broker conversation
Adopting a continuous data model does not mean drowning the client in dashboards or tracking every vanity metric you can find. It means establishing a clear, regular flow of operational intelligence and reading it with commercial context.
Brokers should track, at bare minimum:
- Claims frequency, severity trends, and specific diagnostic categories.
- Absence length, relapse rates, and geographic or departmental hotspots.
- Utilisation patterns across EAPs, private medical pathways, and physical therapy.
- Changes in demographic makeup, shift design, and broader operational structure.
- Active engagement levels with preventive benefits and health interventions.
- Measurable health outcomes following an intervention, rather than surface-level sign-ups.
The critical distinction I look for here is between activity and business impact. An organisation might boast high login figures for a wellbeing app, but that tells you nothing about whether it prevented a single day of sick leave. Conversely, rock-bottom utilisation often points to broken internal communication or benefits that fail to reflect what employees actually face.
The broker's remit must shift toward a coherent risk narrative. What risks are compounding? Which divisions are hit hardest? What changed between this quarter and the last? Which targeted interventions are actually delivering results? What clear evidence can you put before an underwriter to prove the organisation is actively driving down exposure?
That narrative transforms the renewal conversation. Instead of weakly announcing a new wellbeing initiative, the broker demonstrates how an intervention responded to an identified operational risk, what changed as a result, and where residual exposure sits.
There is a clear governance mandate here, too. The Financial Conduct Authority demands that firms secure good outcomes for customers under the Consumer Duty, delivering products that meet genuine customer needs and demonstrate fair value. Whatever the specific distribution model or client classification, the regulatory intent is obvious: advice and insurance designs must be justified by hard evidence of fitness for purpose and measurable value, not commercial habit or superficial engagement numbers.
What this means for senior leadership
For HR, continuous data elevates employee health from a loose collection of perks into a disciplined management system. It exposes exactly where absence is generating cost, shows whether line-manager capability is helping or hurting outcomes, and ensures funding flows to the groups that need support.
For Finance, it delivers certainty. A health strategy built on live trend analysis is straightforward to forecast and defend; reacting in panic to an unexpected premium hike is not. Finance can finally see whether expenditure is reducing systemic risk or merely bankrolling high utilisation without tackling root causes.
For Risk teams, continuous intelligence sharpens the risk register. Long-term sickness, psychosocial risks, and escalating benefit dependencies can be evaluated alongside direct operational and financial exposures. That data gives teeth to workforce planning, operational resilience, and the continuity of critical business roles.
For insurers, transparent data removes the unknown. It might not guarantee an instant discount, but it strips out uncertainty and proves the employer is actively managing its risks rather than sitting back as claims experience unravels.
Four actions before the next renewal
- Establish a quarterly health-risk baseline. Agree on a focused set of metrics spanning claims, absence, benefit uptake, and workforce changes. Define clear owners, set the reporting cadence, and confirm what operational decisions each measure informs.
- Segment the population before rolling out interventions. Interrogate the figures by site, job role, age bracket, and working patterns. Aggregate your data properly and safeguard employee confidentiality; actionable insight is worthless if governance is sloppy.
- Tie every intervention to a commercial outcome. Every material health initiative needs a clear operational hypothesis, a designated target group, and a formal review date. Track participation as an operational input, never as proof of success.
- Start building the renewal case at least 90 days out. Use the final quarter solely to validate your data, build the underwriting submission, and agree on commercial terms. Never use that window to discover the client's risk profile from a standing start.
The most effective brokers build continuous intelligence into the partnership year-round. They help clients stop rationalising last year's claims and start systematically controlling the conditions driving next year's costs.
The January renewal meeting must be where evidence is converted into commercial decisions. If you are only assembling that evidence when the meeting invites go out, you have already lost. Stop treating renewals as an annual paper chase; start building the continuous health narrative that proves your commercial value before the market asks for it.